Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
Trinity Biotech plc - American Depositary Shares each representing 4 A Ordinary Shares (TRIB)
Last trinity biotech plc - american depositary shares each representing 4 a ordinary shares earnings: 10/26 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
trinitybiotech.com/investor-relations
Company Research
Source: GlobeNewswire
DUBLIN, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with a leading bioinformatics company to conduct advanced analysis on clinical trial data for EpiCapture, the company’s PCR-based epigenetic liquid biopsy test for monitoring the risk of prostate cancer progressing to more aggressive forms of the disease. Offering a non-invasive method to monitor disease progression, the EpiCapture test detects DNA methylation patterns associated with high-grade prostate cancer. This collaboration will apply sophisticated bioinformatics tools to enhance the depth of analysis and support the continued development of the test. This collaboration supports the advancement of the EpiCapture test, which is currently in late-stage development, to regulatory approval and commercialization. This initiativ
Show less
Read more
Impact Snapshot
Event Time:
TRIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRIB alerts
High impacting Trinity Biotech plc - American Depositary Shares each representing 4 A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TRIB
News
- Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance TransformationGlobeNewswire
- Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test [Yahoo! Finance]Yahoo! Finance
- Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An 7.85% CAGR - Credence ResearchPR Newswire
- Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An 7.85% CAGR - Credence ResearchPR Newswire
- Trinity Biotech Welcomes Perceptive Advisor’s Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting GrowthGlobeNewswire
TRIB
Sec Filings
- 12/4/25 - Form SCHEDULE
- 11/21/25 - Form 6-K
- 11/18/25 - Form 6-K
- TRIB's page on the SEC website